Genmab A/S American Depositary Shares (GE91)
FSX
Real-time Data
06:00 AM
Day's Range
33.4052 wk Range
20.40Overview - GE91 - Genmab A/S American Depositary Shares
Key Statistics
Valuation
Enterprise Value
19.98B
P/E (Trailing)
‪31.19‬
PEG Ratio
‪-3.39‬
Price / Sales (TTM)
‪5.06‬
Price / Book
‪3.83‬
EV / EBITDA
‪16.34‬
Profitability
Gross Margin
‪92.72%‬
Profit Margin
‪19.07%‬
Operating Margin
‪35.23%‬
Return on Assets
‪8.78%‬
Return on Equity
‪13.99%‬
Ownership
Shares Outstanding
61.43M
Float
589.61M
Held by Insiders
‪0.00%‬
Held by Institutions
‪17.02%‬
Price stats
Beta
‪0.64‬
50-Day Avg
‪28.25‬
200-Day Avg
‪25.18‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - GE91 - Genmab A/S American Depositary Shares
Peers - GE91 - Genmab A/S American Depositary Shares
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- GE91FSXGenmab A/S American Depositary Shares20.90BMarket Cap+17.65%52-week change31.19P/E (Trailing)‪19.07%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - GE91 - Genmab A/S American Depositary Shares
About
Genmab A/S American Depositary Shares represents ownership in Genmab A/S, a Denmark-based biotechnology company focused on developing antibody-based therapies. The company’s business centers on human antibody therapeutics for cancer and other serious diseases, with products and product candidates spanning oncology and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
